H. Lundbeck A/S
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HLUBF research report →
Price Chart
About the company
H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's.
- CEO
- Charl van Zyl
- IPO
- 2022
- Employees
- 5,214
- HQ
- Valby, CR, DK
Get TickerSpark's AI analysis on HLUBF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $5.88B
- P/E
- 10.40
- PEG
- 0.91
- P/S
- 1.26
- P/B
- 1.50
- EV/EBITDA
- 4.78
- Div Yield
- 2.83%
- Gross Margin
- 78.27%
- Op Margin
- 27.21%
- Net Margin
- 15.13%
- ROE
- 15.13%
- ROIC
- 11.62%
Latest fiscal year · YoY change
- Revenue
- $24.30B+10.4%
- Gross Profit
- $19.33B+8.8%
- Op Income
- $6.33B
- Net Income
- $3.18B+1.3%
- EPS
- $3.21+1.3%
- OCF Growth
- +46.9%
- FCF Growth
- +57.0%
- 52W High
- $6.41
- 52W Low
- $4.59
- 50D MA
- $5.49
- 200D MA
- $5.38
- Beta
- 0.26
- RSI (14)
- 73
- Avg Volume
- 32
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Get the HLUBF Q2 '26 earnings-call summary
Create a free account to generate an AI summary of this call — key takeaways, results & guidance, CEO/CFO commentary, Q&A, and a bull vs bear read. Ready in about a minute, and it'll be live for everyone.
Create free account →Already have an account? Log in
- Free Float
- 20.0%
- Shares Outstanding
- 1.06B
- Float Shares
- 212.29M
Our HLUBF coverage
Recent articles, reports, and earnings notes.
No research on HLUBF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HLUBF report →